Need Help? Call 1­-866-­796-­7386
« back to stock screener

  PDLI stock: PDL BioPharma Inc

Current Rating
Strong Buy

Previous Rating:

Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$2.19
Market Cap
350.9M
Sector
Health Care
Div. Growth
-83.30%
P/E
1.9
P/B
0.45
P/S
0.94
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
101.7K
FCF
-
Op. Margin
35.70%
Net Margin
17.90%
ROE
8.50%
ROI
8.30%
ROA
5.60%
EPS Growth
-80.90%
Current Ratio
3.1
Debt/Equity
30.90%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Juniper Pharmaceuticals Inc (JNP) $4.65 - - 53.1M Strong Buy
Encision Inc (ECIA) $0.38 - - 4.7M Strong Buy
Eleven Biotherapeutics Inc (EBIO) $2.14 - - 47.5M Strong Buy
Daxor Corporation (DXR) $7.48 - 0.30% 34.1M Strong Buy
Polydex Pharmaceuticals Ltd (POLXF) $1.50 - - 5.5M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More